![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RANBP17 |
Gene summary for RANBP17 |
![]() |
Gene information | Species | Human | Gene symbol | RANBP17 | Gene ID | 64901 |
Gene name | RAN binding protein 17 | |
Gene Alias | RANBP17 | |
Cytomap | 5q35.1 | |
Gene Type | protein-coding | GO ID | GO:0006403 | UniProtAcc | Q546R4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64901 | RANBP17 | HSIL_HPV_2 | Human | Cervix | HSIL_HPV | 6.89e-12 | 2.72e-01 | 0.0208 |
64901 | RANBP17 | CCI_1 | Human | Cervix | CC | 6.67e-10 | 6.85e-01 | 0.528 |
64901 | RANBP17 | CCI_2 | Human | Cervix | CC | 3.85e-18 | 1.40e+00 | 0.5249 |
64901 | RANBP17 | CCI_3 | Human | Cervix | CC | 2.97e-35 | 1.17e+00 | 0.516 |
64901 | RANBP17 | T3 | Human | Cervix | CC | 9.49e-06 | 1.15e-01 | 0.1389 |
64901 | RANBP17 | HTA11_3410_2000001011 | Human | Colorectum | AD | 7.91e-20 | -6.44e-01 | 0.0155 |
64901 | RANBP17 | HTA11_2487_2000001011 | Human | Colorectum | SER | 6.76e-07 | -6.01e-01 | -0.1808 |
64901 | RANBP17 | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.75e-05 | -6.08e-01 | -0.1207 |
64901 | RANBP17 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.31e-06 | -6.44e-01 | -0.1526 |
64901 | RANBP17 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.93e-11 | -4.84e-01 | -0.1464 |
64901 | RANBP17 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.13e-06 | -4.27e-01 | -0.1001 |
64901 | RANBP17 | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.02e-02 | -6.62e-01 | -0.1706 |
64901 | RANBP17 | HTA11_5212_2000001011 | Human | Colorectum | AD | 9.13e-06 | -8.00e-01 | -0.2061 |
64901 | RANBP17 | HTA11_5216_2000001011 | Human | Colorectum | SER | 9.48e-03 | -7.44e-01 | -0.1462 |
64901 | RANBP17 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.59e-13 | -6.04e-01 | 0.096 |
64901 | RANBP17 | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.20e-02 | -5.68e-01 | 0.0528 |
64901 | RANBP17 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.21e-06 | -5.91e-01 | 0.0338 |
64901 | RANBP17 | HTA11_7696_3000711011 | Human | Colorectum | AD | 7.50e-07 | -3.90e-01 | 0.0674 |
64901 | RANBP17 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.94e-06 | -3.57e-01 | 0.294 |
64901 | RANBP17 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 6.77e-09 | -4.97e-01 | 0.3859 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00725949 | Cervix | CC | establishment of protein localization to organelle | 99/2311 | 422/18723 | 1.23e-10 | 2.11e-08 | 99 |
GO:00069139 | Cervix | CC | nucleocytoplasmic transport | 71/2311 | 301/18723 | 4.04e-08 | 2.54e-06 | 71 |
GO:00511699 | Cervix | CC | nuclear transport | 71/2311 | 301/18723 | 4.04e-08 | 2.54e-06 | 71 |
GO:00345048 | Cervix | CC | protein localization to nucleus | 68/2311 | 290/18723 | 9.91e-08 | 5.25e-06 | 68 |
GO:00170388 | Cervix | CC | protein import | 48/2311 | 206/18723 | 8.62e-06 | 1.98e-04 | 48 |
GO:00511689 | Cervix | CC | nuclear export | 38/2311 | 154/18723 | 1.86e-05 | 3.46e-04 | 38 |
GO:00511707 | Cervix | CC | import into nucleus | 38/2311 | 159/18723 | 3.98e-05 | 6.18e-04 | 38 |
GO:00512368 | Cervix | CC | establishment of RNA localization | 39/2311 | 166/18723 | 4.76e-05 | 7.25e-04 | 39 |
GO:00066067 | Cervix | CC | protein import into nucleus | 37/2311 | 155/18723 | 5.13e-05 | 7.71e-04 | 37 |
GO:00506578 | Cervix | CC | nucleic acid transport | 38/2311 | 163/18723 | 7.06e-05 | 9.85e-04 | 38 |
GO:00506588 | Cervix | CC | RNA transport | 38/2311 | 163/18723 | 7.06e-05 | 9.85e-04 | 38 |
GO:000640310 | Cervix | CC | RNA localization | 43/2311 | 201/18723 | 2.00e-04 | 2.29e-03 | 43 |
GO:00510284 | Cervix | CC | mRNA transport | 31/2311 | 130/18723 | 2.05e-04 | 2.33e-03 | 31 |
GO:00066116 | Cervix | CC | protein export from nucleus | 17/2311 | 57/18723 | 3.61e-04 | 3.75e-03 | 17 |
GO:00159318 | Cervix | CC | nucleobase-containing compound transport | 43/2311 | 222/18723 | 1.72e-03 | 1.30e-02 | 43 |
GO:007259414 | Cervix | HSIL_HPV | establishment of protein localization to organelle | 29/737 | 422/18723 | 2.71e-03 | 2.58e-02 | 29 |
GO:003450412 | Cervix | HSIL_HPV | protein localization to nucleus | 21/737 | 290/18723 | 5.53e-03 | 4.45e-02 | 21 |
GO:0072594 | Colorectum | AD | establishment of protein localization to organelle | 148/3918 | 422/18723 | 7.95e-12 | 1.04e-09 | 148 |
GO:0006913 | Colorectum | AD | nucleocytoplasmic transport | 102/3918 | 301/18723 | 1.00e-07 | 4.85e-06 | 102 |
GO:0051169 | Colorectum | AD | nuclear transport | 102/3918 | 301/18723 | 1.00e-07 | 4.85e-06 | 102 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RANBP17 | SNV | Missense_Mutation | c.3064A>C | p.Ser1022Arg | p.S1022R | Q9H2T7 | protein_coding | tolerated(0.35) | benign(0.01) | TCGA-BR-8080-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
RANBP17 | SNV | Missense_Mutation | c.2708N>G | p.Ile903Ser | p.I903S | Q9H2T7 | protein_coding | deleterious(0) | benign(0.206) | TCGA-BR-8589-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
RANBP17 | SNV | Missense_Mutation | novel | c.608N>A | p.Pro203His | p.P203H | Q9H2T7 | protein_coding | tolerated(0.1) | benign(0.396) | TCGA-CG-4460-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PD |
RANBP17 | SNV | Missense_Mutation | novel | c.1043N>C | p.Val348Ala | p.V348A | Q9H2T7 | protein_coding | tolerated(0.05) | benign(0.443) | TCGA-CG-4460-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PD |
RANBP17 | SNV | Missense_Mutation | rs772152179 | c.218N>A | p.Arg73Gln | p.R73Q | Q9H2T7 | protein_coding | deleterious(0.04) | possibly_damaging(0.722) | TCGA-VQ-A91D-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
RANBP17 | SNV | Missense_Mutation | novel | c.1694T>G | p.Leu565Arg | p.L565R | Q9H2T7 | protein_coding | deleterious(0) | benign(0.025) | TCGA-VQ-A91V-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | PD |
RANBP17 | SNV | Missense_Mutation | novel | c.92N>G | p.Glu31Gly | p.E31G | Q9H2T7 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-VQ-A924-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
RANBP17 | SNV | Missense_Mutation | novel | c.1611G>C | p.Leu537Phe | p.L537F | Q9H2T7 | protein_coding | deleterious(0.01) | probably_damaging(0.979) | TCGA-VQ-A92D-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RANBP17 | insertion | Frame_Shift_Ins | rs779856373 | c.1877_1878insA | p.Leu629ThrfsTer17 | p.L629Tfs*17 | Q9H2T7 | protein_coding | TCGA-VQ-A8PB-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | CR | ||
RANBP17 | insertion | Nonsense_Mutation | novel | c.1564_1565insAAGGAAGAAAAAAGTTTAG | p.Leu522Ter | p.L522* | Q9H2T7 | protein_coding | TCGA-ET-A40R-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |